Literature DB >> 2313128

Death in shigellosis: incidence and risk factors in hospitalized patients.

M L Bennish1, J R Harris, B J Wojtyniak, M Struelens.   

Abstract

The total number of admissions and deaths of patients with shigellosis were ascertained at the Dhaka Treatment Centre of the International Centre for Diarrhoeal Disease Research, Bangladesh, 1974-1988, and the characteristics of 67 patients who died were compared with those of 134 discharged alive. Of 9780 Shigella-infected inpatients, 889 (9.1%) died; 32.3% of deaths occurred in children less than 1 year of age. Fatality rates were highest (10.3%) in Shigella sonnei-infected patients and lowest (6.7%) in Shigella dysenteriae type 1-infected patients. Age less than 1 year, lack of breast feeding in patients 1-2 years of age, hypothermia, severe malnutrition, severe dehydration, altered consciousness, abdominal distension, thrombocytopenia, hypoproteinemia, hyponatremia, hypoglycemia, renal failure, and bacteremia were all significantly more common in case patients. In a multivariate analysis, younger age, decreased serum protein, altered consciousness, and thrombocytopenia were predictive of death. Thus in Bangladesh the fatality rate for hospitalized patients infected with any species of Shigella remains high despite relatively intensive inpatient care, and young, hypoproteinemic patients are at greatest risk of fatal illness.

Entities:  

Mesh:

Year:  1990        PMID: 2313128     DOI: 10.1093/infdis/161.3.500

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Hypoglycemia in critically ill children.

Authors:  E Vincent S Faustino; Eliotte L Hirshberg; Clifford W Bogue
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

3.  Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Authors:  S R Klee; B D Tzschaschel; I Fält; A Kärnell; A A Lindberg; K N Timmis; C A Guzmán
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

Review 5.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

6.  Innate immune responses in children and adults with Shigellosis.

Authors:  R Raqib; S M Mia; F Qadri; T I Alam; N H Alam; A K Chowdhury; M M Mathan; J Andersson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  C reactive protein and prealbumin as markers of disease activity in shigellosis.

Authors:  W A Khan; M A Salam; M L Bennish
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.

Authors:  A A Lima; N L Lima; M C Pinho; E A Barros Juñior; M J Teixeira; M C Martins; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

Review 10.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.